370
Views
9
CrossRef citations to date
0
Altmetric
Review

Advances in the pharmacotherapeutic management of dementia with Lewy bodies

, &
Pages 1643-1653 | Received 12 Jun 2018, Accepted 31 Aug 2018, Published online: 13 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Francesco Panza, Madia Lozupone, Mark Watling & Bruno P. Imbimbo. (2021) Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism. Expert Opinion on Pharmacotherapy 22:3, pages 325-337.
Read now
Kurt A. Jellinger. (2020) How can we best care for people with dementia with Lewy bodies pharmacologically?. Expert Opinion on Pharmacotherapy 21:5, pages 513-515.
Read now
Garam Lee, Jeffrey Cummings, Boris Decourt, James B. Leverenz & Marwan N. Sabbagh. (2019) Clinical drug development for dementia with Lewy bodies: past and present. Expert Opinion on Investigational Drugs 28:11, pages 951-965.
Read now

Articles from other publishers (6)

Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, Kumari Swati, Shreesh Ojha, Anand Prakash, Dhruv Kumar, Rashmi K. Ambasta, Niraj Kumar Jha, Saurabh Kumar Jha & Saikat Dewanjee. (2023) Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Research Reviews 85, pages 101838.
Crossref
Julie Chandler, Mihaela Georgieva, Urvi Desai, Noam Kirson, Henry Lane, Hoi Ching Cheung, Ben Westermeyer & Kevin Biglan. (2022) Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database. Neurology and Therapy 12:1, pages 177-195.
Crossref
Marwan N. Sabbagh, Angela Taylor, Douglas Galasko, James E. Galvin, Jennifer G. Goldman, James B. Leverenz, Kathleen L. Poston, Bradley F. Boeve, David J. Irwin & Joseph F. Quinn. (2023) Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel. Alzheimer's & Dementia: Translational Research & Clinical Interventions 9:1.
Crossref
Rebecca Nicole Burgett, Thomas Michael Farley & Lori Ann Beireis. (2019) Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics. BMJ Case Reports 12:9, pages e230193.
Crossref
Linda A. Hershey & Rhonda Coleman-Jackson. (2019) Pharmacological Management of Dementia with Lewy Bodies. Drugs & Aging 36:4, pages 309-319.
Crossref
Kewal K. JainKewal K. Jain. 2019. The Handbook of Neuroprotection. The Handbook of Neuroprotection 643 766 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.